Literature DB >> 3312810

Immunogold labeling of cerebrovascular and neuritic plaque amyloid fibrils in Alzheimer's disease with an anti-beta protein monoclonal antibody.

S Ikeda1, C W Wong, D Allsop, M Landon, M Kidd, G G Glenner.   

Abstract

A monoclonal antibody raised to a synthetic peptide consisting of residues 8 to 17 of the amyloid beta protein of Alzheimer's disease was employed for immunogold electron microscopic studies on amyloid fibrils of cerebrovascular walls and neuritic plaques in this disease. Electron microscopy revealed a specific gold labeling of the amyloid fibrils in these structures. This provides ultrastructural evidence that beta protein is intimately associated with the amyloid fibril. With previous chemical evidence, this observation supports the concentration that it is an intrinsic component of the fibril.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3312810

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  8 in total

Review 1.  Current status review: cerebral amyloid.

Authors:  L W Duchen
Journal:  Int J Exp Pathol       Date:  1992-08       Impact factor: 1.925

2.  Electron micrograph of diffuse plaques. Initial stage of senile plaque formation in the Alzheimer brain.

Authors:  H Yamaguchi; Y Nakazato; S Hirai; M Shoji; Y Harigaya
Journal:  Am J Pathol       Date:  1989-10       Impact factor: 4.307

3.  Immunohistochemical evidence for the derivation of a peptide ligand from the amyloid beta-protein precursor of Alzheimer disease.

Authors:  D Allsop; C W Wong; S Ikeda; M Landon; M Kidd; G G Glenner
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

4.  Is the "preamyloid" of diffuse plaques in Alzheimer's disease really nonfibrillar?

Authors:  C A Davies; D M Mann
Journal:  Am J Pathol       Date:  1993-12       Impact factor: 4.307

5.  Immunogold labelling of paired helical filaments and amyloid fibrils by specific monoclonal and polyclonal antibodies.

Authors:  S Reig; V Buée-Scherrer; C Mourton-Gilles; A Defossez; A Delacourte; J C Beauvillain; M Mazzuca
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

6.  Ultrastructural localization of argyrophilic substances in diffuse plaques of Alzheimer-type dementia demonstrated by methenamine silver staining.

Authors:  T Yamazaki; H Yamaguchi; K Okamoto; S Hirai
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

7.  Identification of cellular and extracellular sites of amyloid precursor protein extracytoplasmic domain in normal and Alzheimer disease brains.

Authors:  B Tate-Ostroff; R E Majocha; C A Marotta
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

8.  Screening for Small Molecule Inhibitors of Statin-Induced APP C-terminal Toxic Fragment Production.

Authors:  Karen S Poksay; Douglas J Sheffler; Patricia Spilman; Jesus Campagna; Barbara Jagodzinska; Olivier Descamps; Olivia Gorostiza; Alex Matalis; Michael Mullenix; Dale E Bredesen; Nicholas D P Cosford; Varghese John
Journal:  Front Pharmacol       Date:  2017-02-15       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.